v3.26.1
Significant agreements - Novartis Collaboration Agreement (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 30, 2025
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 27, 2023
item
Significant agreements.                
Revenue from collaborative arrangement   $ 629 $ 2,920 $ 1,516 $ 12,897      
Deferred revenue   36,956   36,956   $ 38,469 $ 101,658  
Novartis                
Significant agreements.                
Number of collaboration targets | item               2
Revenue from collaborative arrangement   0 $ 1,491 0 $ 2,896      
Deferred revenue   $ 0   $ 0   $ 0 $ 44,073  
Threshold period of notice required for termination of agreement 90 days